Lotus Nanomedical Inc is categorized under Research and Development Laboratories in Omaha, NE and active since 2010.
Lotus Nanomedical Inc was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Roxanna Namavar at the company’s single location by writing to 4970 South 194th Avenue, Omaha, Nebraska NE 68135 or by phoning (402) 957-2219. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Lotus Nanomedical Inc |
Contact Person: | Roxanna Namavar |
Address: | 4970 South 194th Avenue, Omaha, Nebraska 68135 |
Phone Number: | (402) 957-2219 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Research and Development Laboratories |
SIC Code: | 8731 |
NAICS Code: | 541712 |
Share This Business: |
Lotus Nanomedical Inc was started in 2010 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Roxanna Namavar for inquiries that concern Lotus Nanomedical Inc by calling the company number (402) 957-2219, as your correspondence is most welcome. Additionally, the physical location of the single location of Lotus Nanomedical Inc can be found at the coordinates 41.208163,-96.219824 as well as the street address 4970 South 194th Avenue in Omaha, Nebraska 68135.
For its online presence, you may visit Lotus Nanomedical Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.